Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19- associated cytokine storm syndrome: results of the CHIC study'' by Klopfenstein <i>et al</i>.

Landewé, Robert Bm; Ramiro, Sofia; Mostard, Rémy L M

Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19- associated cytokine storm syndrome: results of the CHIC study'' by Klopfenstein et al.

Landewé, Robert Bm; Ramiro, Sofia; Mostard, Rémy L M.

Afiliação

Landewé RB; Rheumatology, Zuyderland Medical Center, Heerlen, The Netherlands landewe@rlandewe.nl.
Ramiro S; Amsterdam Rheumatology Center, AMC, Amsterdam, The Netherlands.
Mostard RLM; Rheumatology, Zuyderland Medical Center, Heerlen, The Netherlands.

Ann Rheum Dis ; 82(7): e154, 2023 07.

Article em En | MEDLINE | ID: mdl-34162596

Assuntos

COVID-19; Humanos; Glucocorticoides/uso terapêutico; Síndrome da Liberação de Citocina/tratamento farmacológico; Tratamento Farmacológico da COVID-19

Palavras-chave

COVID-19; biological therapy; epidemiology

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article